TOMI Secures First EU Approval for Binary Ionization Tech in Netherlands
Event summary
- TOMI's Binary Ionization Technology (BIT) received approval from the Dutch regulatory authority ctgb on March 24, 2026, marking its first EU member state authorization.
- The approval covers BIT Solution for professional indoor use across the Netherlands, targeting bacteria, yeasts, and mycobacteria in medical, healthcare, industrial, and commercial sectors.
- The authorization was granted under the EU's Biocidal Products Regulation (BPR), which allows for a streamlined mutual recognition pathway in other EU member states.
- TOMI's partner Ster-Pharma is positioned to quickly deploy SteraMist iHP disinfection products in key sectors following the approval.
- The application process began with a submission to the UK HSE in 2017 and was transferred to ctgb in 2020.
The big picture
TOMI's approval in the Netherlands represents a significant milestone in its European strategy, potentially accelerating its market entry across the EU through the BPR's mutual recognition provisions. The approval underscores the growing demand for advanced disinfection solutions in sectors such as healthcare, food processing, and industrial facilities. The strategic partnership with Ster-Pharma positions TOMI to quickly capitalize on this opportunity, though the company's ability to scale its operations and maintain regulatory compliance will be critical to its success.
What we're watching
- Market Expansion
- The pace at which TOMI can secure mutual recognition in other EU member states under the BPR framework.
- Execution Risk
- Whether TOMI can effectively leverage its established network to deliver meaningful impact in high-demand sectors across Europe.
- Regulatory Compliance
- How the streamlined mutual recognition pathway under the BPR will affect TOMI's ability to bring BIT to market across the broader EU.
Related topics